Mirtazapine monotherapy versus combination therapy with mirtazapine and aripiprazole in depressed patients without psychotic features: a 4-week open-label parallel-group study.

Cornelius Schüle; Thomas C Baghai; Daniela Eser; Susanne Hecht; Igor Hermisson; Christoph Born; Sibylle Häfner; Caroline Nothdurfter; Rainer Rupprecht

doi:10.1080/15622970601136203

Mirtazapine monotherapy versus combination therapy with mirtazapine and aripiprazole in depressed patients without psychotic features: a 4-week open-label parallel-group study.

Cornelius Schüle, Thomas C Baghai, Daniela Eser, Susanne Hecht, Igor Hermisson, Christoph Born, Sibylle Häfner, Caroline Nothdurfter, Rainer Rupprecht

Department of Psychiatry and Psychotherapy

Research output: Contribution to journal › Original Article › peer-review

18 Citations (Web of Science)

Original language	English
Pages (from-to)	11-22
Journal	THE WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY
Volume	8
Issue number	2
DOIs	https://doi.org/10.1080/15622970601136203
Publication status	Published - 2007

Keywords

SEROTONIN REUPTAKE INHIBITORS
TREATMENT-RESISTANT DEPRESSION
ANTIPSYCHOTIC-INDUCED AKATHISIA
NEUROLEPTIC-INDUCED AKATHISIA
TERM MAINTENANCE TREATMENT
PLACEBO-CONTROLLED TRIALS
BIPOLAR-II DEPRESSION
LOW-DOSE MIRTAZAPINE
AMISULPRIDE 50 MG
MAJOR DEPRESSION

Access to Document

10.1080/15622970601136203

Cite this

Schüle, C., Baghai, T. C., Eser, D., Hecht, S., Hermisson, I., Born, C., Häfner, S., Nothdurfter, C., & Rupprecht, R. (2007). Mirtazapine monotherapy versus combination therapy with mirtazapine and aripiprazole in depressed patients without psychotic features: a 4-week open-label parallel-group study. THE WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY, 8(2), 11-22. https://doi.org/10.1080/15622970601136203

@article{60510f2d63704026937450de6819826d,

title = "Mirtazapine monotherapy versus combination therapy with mirtazapine and aripiprazole in depressed patients without psychotic features: a 4-week open-label parallel-group study.",

keywords = "SEROTONIN REUPTAKE INHIBITORS, TREATMENT-RESISTANT DEPRESSION, ANTIPSYCHOTIC-INDUCED AKATHISIA, NEUROLEPTIC-INDUCED AKATHISIA, TERM MAINTENANCE TREATMENT, PLACEBO-CONTROLLED TRIALS, BIPOLAR-II DEPRESSION, LOW-DOSE MIRTAZAPINE, AMISULPRIDE 50 MG, MAJOR DEPRESSION",

author = "Cornelius Sch{\"u}le and Baghai, {Thomas C} and Daniela Eser and Susanne Hecht and Igor Hermisson and Christoph Born and Sibylle H{\"a}fner and Caroline Nothdurfter and Rainer Rupprecht",

year = "2007",

doi = "10.1080/15622970601136203",

language = "English",

volume = "8",

pages = "11--22",

journal = "THE WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY",

issn = "1562-2975",

number = "2",

}

Schüle, C, Baghai, TC, Eser, D, Hecht, S, Hermisson, I, Born, C, Häfner, S, Nothdurfter, C & Rupprecht, R 2007, 'Mirtazapine monotherapy versus combination therapy with mirtazapine and aripiprazole in depressed patients without psychotic features: a 4-week open-label parallel-group study.', THE WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY, vol. 8, no. 2, pp. 11-22. https://doi.org/10.1080/15622970601136203

Mirtazapine monotherapy versus combination therapy with mirtazapine and aripiprazole in depressed patients without psychotic features: a 4-week open-label parallel-group study. / Schüle, Cornelius; Baghai, Thomas C; Eser, Daniela et al.
In: THE WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY, Vol. 8, No. 2, 2007, p. 11-22.

Research output: Contribution to journal › Original Article › peer-review

TY - JOUR

T1 - Mirtazapine monotherapy versus combination therapy with mirtazapine and aripiprazole in depressed patients without psychotic features: a 4-week open-label parallel-group study.

AU - Schüle, Cornelius

AU - Baghai, Thomas C

AU - Eser, Daniela

AU - Hecht, Susanne

AU - Hermisson, Igor

AU - Born, Christoph

AU - Häfner, Sibylle

AU - Nothdurfter, Caroline

AU - Rupprecht, Rainer

PY - 2007

Y1 - 2007

KW - SEROTONIN REUPTAKE INHIBITORS

KW - TREATMENT-RESISTANT DEPRESSION

KW - ANTIPSYCHOTIC-INDUCED AKATHISIA

KW - NEUROLEPTIC-INDUCED AKATHISIA

KW - TERM MAINTENANCE TREATMENT

KW - PLACEBO-CONTROLLED TRIALS

KW - BIPOLAR-II DEPRESSION

KW - LOW-DOSE MIRTAZAPINE

KW - AMISULPRIDE 50 MG

KW - MAJOR DEPRESSION

U2 - 10.1080/15622970601136203

DO - 10.1080/15622970601136203

M3 - Original Article

C2 - 17455104

SN - 1562-2975

VL - 8

SP - 11

EP - 22

JO - THE WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY

JF - THE WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY

IS - 2

ER -